Key result
miR-25 agomir mitigates myocardial ischemia-reperfusion injury by targeting HMGB1 in a rat model.
Why the study?
Having previously confirmed miR-25 targets HMGB1, the authors sought to investigate whether miR-25 improves myocardial ischemia-reperfusion injury in vivo by targeting HMGB1.
Does miR-25 agomir reduce myocardial injury in a rat model of myocardial ischemia-reperfusion injury?
Does miR-25 agomir reduce myocardial injury in a rat model of myocardial ischemia-reperfusion injury?
MiR-25 mitigates myocardial ischemia-reperfusion injury in a rat model by targeting HMGB1, highlighting a potential therapeutic pathway for cardioprotection.
Supports miR-25/HMGB1 axis as cardioprotective target in preclinical models; hypothesis-generating and should not yet change practice.
BACKGROUND: We previously confirmed the targeting of high-mobility group box 1 (HMGB1) by miR-25. This project aims to further investigate whether miR-25 improves myocardial ischemia-reperfusion injury (IRI) in vivo by targeting HMGB1. METHODS: A rat model of myocardial IRI was established by the ligation of the left anterior descending coronary artery for 45 minutes followed by 2, 4, or 6 hours reperfusion. The expression of miR-25, HMGB1, and apoptosis-related proteins in the myocardium was determined by quantitative real-time polymerase chain reaction (PCR) and western blotting. The activities of myocardial enzymes and the release of inflammatory cytokines were evaluated by enzyme-linked immunosorbent assay. Evans blue/triphenyltetrazolium chloride double staining was performed to assess infarct size. Myocardial apoptosis was detected by terminal deoxynucleotidyl transferase dUTP nick end labeling staining. RESULTS: MiR-25 expression was significantly downregulated, while HMGB1 was highly expressed at the mRNA and protein levels in myocardial tissues after induction of the IRI model. MiR-25 agomir administration suppressed the expression of HMGB1 in myocardial tissues. Furthermore, administration of both miR-25 agomir and lentivirus-mediated short hairpin RNA (shRNA) interference targeting HMGB1 sh-HMGB1 resulted in reduced serum myocardial enzyme activities, cytokine secretion, and myocardial apoptosis during myocardial IRI. CONCLUSION: MiR-25 mitigated myocardial IRI-induced damage by targeting HMGB1.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2019) studied Myocardial ischemia-reperfusion injury. miR-25 agomir and lentivirus-mediated shRNA targeting HMGB1 was evaluated on Myocardial enzyme activities, cytokine secretion, and myocardial apoptosis. Administration of miR-25 agomir mitigated myocardial ischemia-reperfusion injury-induced damage by targeting HMGB1, reducing enzyme activities, cytokine secretion, and apoptosis in a rat model.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: